Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Netakimab (Anti-CTLA-8 / IL-17a) For research use only.
Not for use in humans.

Netakimab (Anti-CTLA-8 / IL-17a)

Synonyms:

Netakimab (Anti-CTLA-8 / IL-17a) is a humanized monoclonal antibody against interleukin-17 (IL-17) with the potential to treat moderate to severe plaque psoriasis. MW: 145.74 KD.

Netakimab (Anti-CTLA-8 / IL-17a)

Purity & Quality Control

≥99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Netakimab (Anti-CTLA-8 / IL-17a) is a humanized monoclonal antibody against interleukin-17 (IL-17) with the potential to treat moderate to severe plaque psoriasis. MW: 145.74 KD.

Product Details

CAS No. 1796570-08-5
Molecular Weight 145.74
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Netakimab (Anti-CTLA-8 / IL-17a) | Netakimab (Anti-CTLA-8 / IL-17a) supplier | purchase Netakimab (Anti-CTLA-8 / IL-17a) | Netakimab (Anti-CTLA-8 / IL-17a) cost | Netakimab (Anti-CTLA-8 / IL-17a) manufacturer | order Netakimab (Anti-CTLA-8 / IL-17a) | Netakimab (Anti-CTLA-8 / IL-17a) distributor